Table 1 Clinical data on the patients at the time of biopsies, cohort 1: patients with recently diagnosed and with treatment-resistant myositis (marked with *)

Patient	Age	Sex	Bohan and Peter diagnostic criteria	Biopsy site	Treatment at time of biopsy, mg/day
1	53	F	Probable polymyositis	Mus vastus lat	None
2	59	F	Probable polymyositis	Mus deltoideus	Pred 5, NSAID
3	76	F	Definite polymyositis	Mus vastus lat	None
4	44	F	Definite polymyositis	Mus vastus lat	None
5	65	F	Definite dermatomyositis	Mus vastus lat	Pred 15
6	72	F	Definite polymyositis	Mus vastus lat	Pred 15–40, AZA
7	60	M	Probable polymyositis	Mus vastus lat	NSAID
8	56	M	Definite polymyositis	Mus vastus lat	NSAID
9	55	M	Probable dermatomyositis	Mus vastus lat	None
10*	67	M	Definite dermatomyositis	Mus vastus lat	AZA, MTX, Cs
11*	54	F	Probable polymyositis	Mus tib ant	AZA, MTX, Cs
12*	61	F	Definite polymyositis	Mus vastus lat	AZA, MTX, Cs

Ant, anterior; AZA, azathioprine; Cs, ciclosporine; F, female; lat, lateralis; M, male; Mus, musculus; MTX, methotrexate; NSAID, non-steroidal anti-inflammatory drugs; tib, tibialis; Pred, prednisolone.